Cite
HARVARD Citation
Honore, P. et al. (2023). After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?. Critical care medicine. 51 (2), pp. e68-e69. [Online].